ArticleArchives of virology2026
Multiplex PCR and nanopore sequencing reveal the genetic stability of Hantaan virus in Xi'an, China.
Article in Archives of virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Hantavirus: A Comprehensive Narrative Review of Virology, Epidemiology, Pathogenesis, Clinical Manifestations, Diagnostics, and Emerging Therapeutic Strategies.Reviews in medical virology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Hantaan virus (HTNV), a negative-sense RNA virus, is the primary causative agent of Hemorrhagic Fever with Renal Syndrome (HFRS) and is predominantly endemic in Eurasia, with the highest incidence reported in China. In this study, we applied a multiplex PCR amplification strategy combined with Oxford Nanopore GridION sequencing to analyze 33 HTNV-positive samples collected from Xi’an City, Shaanxi Province, China, between 2010 and 2022. The sample set included four cell culture isolates and 29 rodent lung tissue specimens. A total of 29 primer pairs targeting the S, M, and L genomic segments were used for whole-genome amplification. All samples were successfully sequenced, achieving > 98.2% genome coverage across all three segments (S, M, and L). Sensitivity evaluation demonstrated stable and uniform amplification at RNA concentrations ≥ 10⁴ copies/mL. Phylogenetic analysis revealed that all 33 HTNV genomes clustered within the H4 lineage and shared 98.1%–99.9% nucleotide identity with strains previously reported in Tianjin and Guizhou Provinces. The selection pressure analysis indicated that purifying selection is the dominant force across all four proteins. The Xi’an strains demonstrated sustained genetic stability over the surveillance period. This study establishes a rapid, sensitive, and reliable whole-genome sequencing approach for HTNV, offering a valuable tool for molecular surveillance, epidemiological tracking, and the evaluation of vaccine efficacy in HFRS-endemic regions.
Indexed as
Identifiers
41699188What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.